According to data from MarketBeat, STERIS currently has an average rating of “Moderate Buy” and an average target price of $234.

Source: https://www.etfdailynews.com/2023/02/13/advisors-asset-management-inc-has-1-10-million-holdings-in-steris-plc-nyseste/

Achmea Investment Management B.V. cut its stake in STERIS plc () by 40.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC).

Source: https://www.americanbankingnews.com/2023/05/16/achmea-investment-management-b-v-sells-4340-shares-of-steris-plc-nyseste.html

Fiduciary Alliance LLC purchased a new position in STERIS during the 2nd quarter valued at $31,000.

Source: https://www.dailypolitical.com/2023/10/22/fiduciary-trust-co-sells-525-shares-of-steris-plc-nyseste.html

Finally, KeyCorp upped their target price on shares of STERIS from $254.00 to $258.00 and gave the stock an “overweight” rating in a research report on Thursday, August 3rd.

Source: https://www.dailypolitical.com/2023/10/22/fiduciary-trust-co-sells-525-shares-of-steris-plc-nyseste.html

Stephens reaffirmed an “overweight” rating and issued a $220.00 price objective on shares of STERIS in a research note on Thursday, February 9th.

Source: https://www.etfdailynews.com/2023/04/01/steris-plc-nyseste-stock-holdings-lifted-by-crossmark-global-holdings-inc/